APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Artificial Blood Products

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Artificial Blood Products Market Outlook and Growth Opportunities 2026

Report ID 173967450430 December 2025190 pages

Choose your research edition.

Industry ResearchArtificial Blood Products Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Blood Products Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Artificial Blood Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Blood Products Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Blood Products Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Artificial Blood Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Artificial Blood Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Artificial Blood Products market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Artificial Blood Products market include SpheriTech Ltd., NuvOx Pharma, KaloCyte Inc., HEMARINA SA, HbO2 Therapeutics and Aurum Biosciences Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Artificial Blood Products market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Artificial Blood Products and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Artificial Blood Products sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Artificial Blood Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Artificial Blood Products Segment by Company

SpheriTech Ltd.

NuvOx Pharma

KaloCyte Inc.

HEMARINA SA

HbO2 Therapeutics

Aurum Biosciences Ltd.

Artificial Blood Products Segment by Type

Perfluorocarbon-based Oxygen Carrier (PFBOC)

Hemoglobin-based Oxygen Carrier (HBOC)

Artificial Blood Products Segment by Application

Military

Civil

Artificial Blood Products Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Artificial Blood Products status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Artificial Blood Products market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Artificial Blood Products significant trends, drivers, influence factors in global and regions.

6. To analyze Artificial Blood Products competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Blood Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Blood Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Blood Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Artificial Blood Products market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Artificial Blood Products industry.

Chapter 3: Detailed analysis of Artificial Blood Products manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Artificial Blood Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Artificial Blood Products in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Artificial Blood Products Industry Trends Table 2. Artificial Blood Products Industry Drivers Table 3. Artificial Blood Products Industry Opportunities and Challenges Table 4. Artificial Blood Products Industry Restraints Table 5. Global Artificial Blood Products Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Artificial Blood Products Revenue Share by Company (2021-2026) Table 7. Global Artificial Blood Products Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Artificial Blood Products Sales Volume Share by Company (2021-2026) Table 9. Global Artificial Blood Products Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Artificial Blood Products Company Ranking, (2024-2026) & (USD Million) Table 11. Global Artificial Blood Products Key Company Manufacturing Base & Headquarters Table 12. Global Artificial Blood Products Company, Product Type & Application Table 13. Global Artificial Blood Products Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Artificial Blood Products by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Perfluorocarbon-based Oxygen Carrier (PFBOC) Table 18. Significant Companies of Hemoglobin-based Oxygen Carrier (HBOC) Table 19. Global Artificial Blood Products Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Artificial Blood Products Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Artificial Blood Products Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Artificial Blood Products Sales Volume Share by Type (2021-2026) Table 23. Global Artificial Blood Products Sales Volume Share by Type (2027-2032) Table 24. Global Artificial Blood Products Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Artificial Blood Products Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Artificial Blood Products Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Artificial Blood Products Sales Value Share by Type (2021-2026) Table 28. Global Artificial Blood Products Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Military Table 30. Significant Companies of Civil Table 31. Global Artificial Blood Products Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Artificial Blood Products Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Artificial Blood Products Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Artificial Blood Products Sales Volume Share by Application (2021-2026) Table 35. Global Artificial Blood Products Sales Volume Share by Application (2027-2032) Table 36. Global Artificial Blood Products Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Artificial Blood Products Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Artificial Blood Products Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Artificial Blood Products Sales Value Share by Application (2021-2026) Table 40. Global Artificial Blood Products Sales Value Share by Application (2027-2032) Table 41. Global Artificial Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Artificial Blood Products Sales by Region (2021-2026) & (K Units) Table 43. Global Artificial Blood Products Sales Market Share by Region (2021-2026) Table 44. Global Artificial Blood Products Sales by Region (2027-2032) & (K Units) Table 45. Global Artificial Blood Products Sales Market Share by Region (2027-2032) Table 46. Global Artificial Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Artificial Blood Products Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Artificial Blood Products Sales Value Share by Region (2021-2026) Table 49. Global Artificial Blood Products Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Artificial Blood Products Sales Value Share by Region (2027-2032) Table 51. Global Artificial Blood Products Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Artificial Blood Products Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Artificial Blood Products Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Artificial Blood Products Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Artificial Blood Products Sales by Country (2021-2026) & (K Units) Table 56. Global Artificial Blood Products Sales Market Share by Country (2021-2026) Table 57. Global Artificial Blood Products Sales by Country (2027-2032) & (K Units) Table 58. Global Artificial Blood Products Sales Market Share by Country (2027-2032) Table 59. Global Artificial Blood Products Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Artificial Blood Products Sales Value Market Share by Country (2021-2026) Table 61. Global Artificial Blood Products Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Artificial Blood Products Sales Value Market Share by Country (2027-2032) Table 63. SpheriTech Ltd. Company Information Table 64. SpheriTech Ltd. Business Overview Table 65. SpheriTech Ltd. Artificial Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. SpheriTech Ltd. Artificial Blood Products Product Portfolio Table 67. SpheriTech Ltd. Recent Development Table 68. NuvOx Pharma Company Information Table 69. NuvOx Pharma Business Overview Table 70. NuvOx Pharma Artificial Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. NuvOx Pharma Artificial Blood Products Product Portfolio Table 72. NuvOx Pharma Recent Development Table 73. KaloCyte Inc. Company Information Table 74. KaloCyte Inc. Business Overview Table 75. KaloCyte Inc. Artificial Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. KaloCyte Inc. Artificial Blood Products Product Portfolio Table 77. KaloCyte Inc. Recent Development Table 78. HEMARINA SA Company Information Table 79. HEMARINA SA Business Overview Table 80. HEMARINA SA Artificial Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. HEMARINA SA Artificial Blood Products Product Portfolio Table 82. HEMARINA SA Recent Development Table 83. HbO2 Therapeutics Company Information Table 84. HbO2 Therapeutics Business Overview Table 85. HbO2 Therapeutics Artificial Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. HbO2 Therapeutics Artificial Blood Products Product Portfolio Table 87. HbO2 Therapeutics Recent Development Table 88. Aurum Biosciences Ltd. Company Information Table 89. Aurum Biosciences Ltd. Business Overview Table 90. Aurum Biosciences Ltd. Artificial Blood Products Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Aurum Biosciences Ltd. Artificial Blood Products Product Portfolio Table 92. Aurum Biosciences Ltd. Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. Artificial Blood Products Distributors List Table 96. Artificial Blood Products Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Artificial Blood Products Product Image Figure 2. Global Artificial Blood Products Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Blood Products Sales Value (2021-2032) & (US$ Million) Figure 4. Global Artificial Blood Products Sales (2021-2032) & (K Units) Figure 5. Global Artificial Blood Products Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Artificial Blood Products Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Perfluorocarbon-based Oxygen Carrier (PFBOC) Image Figure 10. Hemoglobin-based Oxygen Carrier (HBOC) Image Figure 11. Global Artificial Blood Products Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Artificial Blood Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Artificial Blood Products Sales Volume Share by Type (2021-2032) Figure 14. Global Artificial Blood Products Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Artificial Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Artificial Blood Products Sales Value Share by Type (2021-2032) Figure 17. Military Image Figure 18. Civil Image Figure 19. Global Artificial Blood Products Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Artificial Blood Products Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Artificial Blood Products Sales Volume Share by Application (2021-2032) Figure 22. Global Artificial Blood Products Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Artificial Blood Products Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Artificial Blood Products Sales Value Share by Application (2021-2032) Figure 25. Global Artificial Blood Products Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Artificial Blood Products Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Artificial Blood Products Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Artificial Blood Products Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Artificial Blood Products Sales Value (2021-2032) & (US$ Million) Figure 30. North America Artificial Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Artificial Blood Products Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Artificial Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Artificial Blood Products Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Artificial Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Artificial Blood Products Sales Value (2021-2032) & (US$ Million) Figure 36. South America Artificial Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Artificial Blood Products Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Artificial Blood Products Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Artificial Blood Products Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Artificial Blood Products Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Artificial Blood Products Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Artificial Blood Products Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Artificial Blood Products Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Perfluorocarbon-based Oxygen Carrier (PFBOC)
  • Hemoglobin-based Oxygen Carrier (HBOC)
Applications
  • Military
  • Civil
Companies covered
  • SpheriTech Ltd.
  • NuvOx Pharma
  • KaloCyte Inc.
  • HEMARINA SA
  • HbO2 Therapeutics
  • Aurum Biosciences Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Artificial Blood Products Sales Value (2021-2032)
  4. 1.2.2 Global Artificial Blood Products Sales Volume (2021-2032)
  5. 1.2.3 Global Artificial Blood Products Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Artificial Blood Products Market Dynamics
  1. 2.1 Artificial Blood Products Industry Trends
  2. 2.2 Artificial Blood Products Industry Drivers
  3. 2.3 Artificial Blood Products Industry Opportunities and Challenges
  4. 2.4 Artificial Blood Products Industry Restraints
3 Artificial Blood Products Market by Company
  1. 3.1 Global Artificial Blood Products Company Revenue Ranking in 2025
  2. 3.2 Global Artificial Blood Products Revenue by Company (2021-2026)
  3. 3.3 Global Artificial Blood Products Sales Volume by Company (2021-2026)
  4. 3.4 Global Artificial Blood Products Average Price by Company (2021-2026)
  5. 3.5 Global Artificial Blood Products Company Ranking (2024-2026)
  6. 3.6 Global Artificial Blood Products Company Manufacturing Base and Headquarters
  7. 3.7 Global Artificial Blood Products Company Product Type and Application
  8. 3.8 Global Artificial Blood Products Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Artificial Blood Products Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Artificial Blood Products Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Artificial Blood Products Market by Type
  1. 4.1 Artificial Blood Products Type Introduction
  2. 4.1.1 Perfluorocarbon-based Oxygen Carrier (PFBOC)
  3. 4.1.2 Hemoglobin-based Oxygen Carrier (HBOC)
  4. 4.2 Global Artificial Blood Products Sales Volume by Type
  5. 4.2.1 Global Artificial Blood Products Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Artificial Blood Products Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Artificial Blood Products Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Artificial Blood Products Sales Value by Type
  9. 4.3.1 Global Artificial Blood Products Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Artificial Blood Products Sales Value by Type (2021-2032)
  11. 4.3.3 Global Artificial Blood Products Sales Value Share by Type (2021-2032)
5 Artificial Blood Products Market by Application
  1. 5.1 Artificial Blood Products Application Introduction
  2. 5.1.1 Military
  3. 5.1.2 Civil
  4. 5.2 Global Artificial Blood Products Sales Volume by Application
  5. 5.2.1 Global Artificial Blood Products Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Artificial Blood Products Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Artificial Blood Products Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Artificial Blood Products Sales Value by Application
  9. 5.3.1 Global Artificial Blood Products Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Artificial Blood Products Sales Value by Application (2021-2032)
  11. 5.3.3 Global Artificial Blood Products Sales Value Share by Application (2021-2032)
6 Artificial Blood Products Regional Sales and Value Analysis
  1. 6.1 Global Artificial Blood Products Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Artificial Blood Products Sales by Region (2021-2032)
  3. 6.2.1 Global Artificial Blood Products Sales by Region: 2021-2026
  4. 6.2.2 Global Artificial Blood Products Sales by Region (2027-2032)
  5. 6.3 Global Artificial Blood Products Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Artificial Blood Products Sales Value by Region (2021-2032)
  7. 6.4.1 Global Artificial Blood Products Sales Value by Region: 2021-2026
  8. 6.4.2 Global Artificial Blood Products Sales Value by Region (2027-2032)
  9. 6.5 Global Artificial Blood Products Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Artificial Blood Products Sales Value (2021-2032)
  12. 6.6.2 North America Artificial Blood Products Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Artificial Blood Products Sales Value (2021-2032)
  15. 6.7.2 Europe Artificial Blood Products Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Artificial Blood Products Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Artificial Blood Products Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Artificial Blood Products Sales Value (2021-2032)
  21. 6.9.2 South America Artificial Blood Products Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Artificial Blood Products Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Artificial Blood Products Sales Value Share by Country, 2025 VS 2032
7 Artificial Blood Products Country-level Sales and Value Analysis
  1. 7.1 Global Artificial Blood Products Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Artificial Blood Products Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Artificial Blood Products Sales by Country (2021-2032)
  4. 7.3.1 Global Artificial Blood Products Sales by Country (2021-2026)
  5. 7.3.2 Global Artificial Blood Products Sales by Country (2027-2032)
  6. 7.4 Global Artificial Blood Products Sales Value by Country (2021-2032)
  7. 7.4.1 Global Artificial Blood Products Sales Value by Country (2021-2026)
  8. 7.4.2 Global Artificial Blood Products Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Artificial Blood Products Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Artificial Blood Products Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Artificial Blood Products Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Artificial Blood Products Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Artificial Blood Products Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Artificial Blood Products Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Artificial Blood Products Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Artificial Blood Products Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Artificial Blood Products Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Artificial Blood Products Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Artificial Blood Products Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Artificial Blood Products Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Artificial Blood Products Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Artificial Blood Products Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Artificial Blood Products Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Artificial Blood Products Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Artificial Blood Products Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Artificial Blood Products Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Artificial Blood Products Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Artificial Blood Products Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Artificial Blood Products Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Artificial Blood Products Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Artificial Blood Products Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Artificial Blood Products Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Artificial Blood Products Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Artificial Blood Products Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Artificial Blood Products Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Artificial Blood Products Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Artificial Blood Products Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Artificial Blood Products Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 SpheriTech Ltd.
  2. 8.1.1 SpheriTech Ltd. Company Information
  3. 8.1.2 SpheriTech Ltd. Business Overview
  4. 8.1.3 SpheriTech Ltd. Artificial Blood Products Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 SpheriTech Ltd. Artificial Blood Products Product Portfolio
  6. 8.1.5 SpheriTech Ltd. Recent Developments
  7. 8.2 NuvOx Pharma
  8. 8.2.1 NuvOx Pharma Company Information
  9. 8.2.2 NuvOx Pharma Business Overview
  10. 8.2.3 NuvOx Pharma Artificial Blood Products Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 NuvOx Pharma Artificial Blood Products Product Portfolio
  12. 8.2.5 NuvOx Pharma Recent Developments
  13. 8.3 KaloCyte Inc.
  14. 8.3.1 KaloCyte Inc. Company Information
  15. 8.3.2 KaloCyte Inc. Business Overview
  16. 8.3.3 KaloCyte Inc. Artificial Blood Products Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 KaloCyte Inc. Artificial Blood Products Product Portfolio
  18. 8.3.5 KaloCyte Inc. Recent Developments
  19. 8.4 HEMARINA SA
  20. 8.4.1 HEMARINA SA Company Information
  21. 8.4.2 HEMARINA SA Business Overview
  22. 8.4.3 HEMARINA SA Artificial Blood Products Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 HEMARINA SA Artificial Blood Products Product Portfolio
  24. 8.4.5 HEMARINA SA Recent Developments
  25. 8.5 HbO2 Therapeutics
  26. 8.5.1 HbO2 Therapeutics Company Information
  27. 8.5.2 HbO2 Therapeutics Business Overview
  28. 8.5.3 HbO2 Therapeutics Artificial Blood Products Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 HbO2 Therapeutics Artificial Blood Products Product Portfolio
  30. 8.5.5 HbO2 Therapeutics Recent Developments
  31. 8.6 Aurum Biosciences Ltd.
  32. 8.6.1 Aurum Biosciences Ltd. Company Information
  33. 8.6.2 Aurum Biosciences Ltd. Business Overview
  34. 8.6.3 Aurum Biosciences Ltd. Artificial Blood Products Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Aurum Biosciences Ltd. Artificial Blood Products Product Portfolio
  36. 8.6.5 Aurum Biosciences Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Artificial Blood Products Value Chain Analysis
  2. 9.1.1 Artificial Blood Products Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Artificial Blood Products Sales Mode & Process
  6. 9.2 Artificial Blood Products Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Artificial Blood Products Distributors
  9. 9.2.3 Artificial Blood Products Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst